Provided by Tiger Fintech (Singapore) Pte. Ltd.

XILIO THERAPEUTICS, INC.

0.7939
-0.0161-1.99%
Post-market: 0.7902-0.0037-0.47%16:33 EDT
Volume:97.11K
Turnover:78.50K
Market Cap:41.10M
PE:-0.73
High:0.8244
Open:0.8019
Low:0.7879
Close:0.8100
Loading ...
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Correspondence

Form CORRESP - Correspondence
Apr 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 05, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 01, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 05, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Nov 10, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]